# ARPA-H **Entity class:** Government research agency **Domain:** Health Research Funding / Program-Manager Model **Doc Type:** Institution Node **Maturity:** Developing **Collection:** [[collections/Neurotech|Neurotech]] **Primary Sources:** [[research/Research Inferences|Research Inferences]] (INF-0332, INF-0456) ## Definition **The Advanced Research Projects Agency for Health (ARPA-H) is the U.S. federal agency, created within the Department of Health and Human Services in 2022, that funds high-risk health research on the program-manager model pioneered by [[wiki/DARPA|DARPA]].** It works with the [[wiki/National Institutes of Health|National Institutes of Health]] while running its own programs, each led by a fixed-term program manager with a defined technical objective. Its operating plan lists $1.5 billion in discretionary budget authority for both FY2025 and FY2026; the administration's FY2026 request proposed $945 million. ## Programs relevant to the corpus - **AEGIS:** an Innovative Genomics Institute–led consortium funded with up to $27.7 million to build personalized in vivo gene editing for children with inborn errors of metabolism, the infrastructure behind cases like [[wiki/Baby KJ|Baby KJ]]. - **FRONT (Functional Repair of Neocortical Tissue):** grafts of neocortical precursor tissue derived from induced pluripotent stem cells, surgically engrafted to mature in vivo and restore cognitive function. The program targets an estimated 20 million U.S. adults with chronic neocortical damage; *MIT Technology Review* reported a commitment of up to $175 million (single source, 15 October 2026). ## Forward Capability ARPA-H funds platforms rather than papers, which makes it the federal sponsor most likely to carry continuity-relevant capability through its unprofitable middle: bespoke gene editing, neural tissue replacement and the manufacturing analytics individualized therapy requires. FRONT places the agency inside the identity question the register raises for cell replacement: a graft that restores function also tests how much of a person survives the substitution of tissue. ## Open Questions - FRONT performers, award sizes and milestones. - AEGIS milestones and the first umbrella filing under the [[wiki/Plausible Mechanism Framework|Plausible Mechanism Framework]]. - The agency's FY2027 appropriation; a March 2026 coalition asked Congress for at least $1.7 billion a year through FY2029. ## Research Inferences These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. Proposed IDs above INF-0500 come from the 2026-10-23 cycle: [[research/Research Inferences Integration Report - 2026-10-23|Research Inferences Integration Report — 2026-10-23]] · [[research/Research Inferences Integration Audit - 2026-10-23|Research Inferences Integration Audit — 2026-10-23]]. - **INF-0332 — Established.** An IGI-led consortium received up to $27.7 million from ARPA-H to develop personalized in vivo editing for children with inborn errors. Dedicated federal funding for bespoke editing infrastructure signals that the state is building the pipeline, not merely permitting it. - **INF-0455 — Established.** Concentrated authority in a program manager with a fixed term and a specific objective is the mechanism behind the agency's record. Copying the structure — as ARIA and ARPA-H have — reproduces the capability, which is why the model proliferates. - **INF-0456 — Established.** A health agency built on the high-risk research model funds capability-building programs rather than investigator-initiated studies. That difference determines what gets built: infrastructure and platforms rather than papers. - **INF-0431 — Plausible.** Replacing lost neurons risks the information they carried, which makes neural regeneration an identity question rather than only a medical one. Any successful therapy here will produce the first clinical data on how much of a person survives cell turnover. ## Relationships - **model_from:** [[wiki/DARPA|DARPA]] (program-manager structure). - **peer_agency:** [[wiki/Advanced Research and Invention Agency|Advanced Research and Invention Agency]] (UK). - **sibling_agency:** [[wiki/National Institutes of Health|National Institutes of Health]]. - **funds:** AEGIS personalized editing → [[wiki/Baby KJ|Baby KJ]] lineage · [[wiki/Base Editing|Base Editing]] · [[wiki/Prime Editing|Prime Editing]]. - **funds:** FRONT neocortical repair → [[wiki/Brain Preservation|Brain Preservation]] and [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] cluster adjacency. - **regulatory_partner:** [[wiki/United States Food and Drug Administration|United States Food and Drug Administration]]. - **ecosystem:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] · [[collections/Neurotech|Neurotech]]. ## Sources - [ARPA-H FRONT program page](https://arpa-h.gov/explore-funding/programs/FRONT) - [ARPA-H launches program to restore brain function — HHS](https://hhs.gov/press-room/arpa-h-launches-program-to-restore-brain-function-patient-independence.html) - [FY2026 ARPA-H Operating Plan, March 2026](https://arpa-h.gov/sites/default/files/2026-03/FY2026_ARPA-H_Operating_Plan.pdf) - [Six wild ideas for perpetuating your mind — MIT Technology Review, 15 October 2026](https://www.technologyreview.com/2026/10/15/1145819/six-wild-ideas-perpetuating-your-mind-cognitive-immortality/) - [ASGCT ARPA-H funding sign-on letter, March 2026](https://www.asgct.org/advocacy/policy-statements/arpa-h-funding-sign-on) As of 23 October 2026.